Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Download
Paper published in a journal (Scientific congresses and symposiums)
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
Heusschen, Roy
;
Muller, Joséphine
;
Binsfeld, Marilène
et al.
2016
•
In
Belgian Journal of Hematology
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/193026
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Abstract BHS2016.pdf
Author preprint (390.2 kB)
Download
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Keywords :
SRC kinase; saracatinib; multiple myeloma; bone disease
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Heusschen, Roy
;
Université de Liège > GIGA-R : Hématologie
Muller, Joséphine
;
Université de Liège > GIGA-R : Hématologie
Binsfeld, Marilène
;
Université de Liège > GIGA-R : Hématologie
Marty, Caroline
Plougonven, Erwan
;
Université de Liège > Department of Chemical Engineering > Génie chimique - Procédés et développement durable
DUBOIS, Sophie
;
Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Mahli, Nadia
Moermans, Karen
Carmeliet, Geert
Léonard, Angélique
;
Université de Liège > Department of Chemical Engineering > Génie chimique - Procédés et développement durable
BARON, Frédéric
;
Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Cohen-Solal, Martine
Vanderkerken, Karin
BEGUIN, Yves
;
Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Menu, Eline
CAERS, Jo
;
Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
More authors (6 more)
Less
Language :
English
Title :
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
Publication date :
2016
Event name :
31st General Annual Meeting of the Belgian Hematological Society
Event date :
29-30 January 2016
Journal title :
Belgian Journal of Hematology
ISSN :
2033-3749
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 February 2016
Statistics
Number of views
93 (9 by ULiège)
Number of downloads
103 (3 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi